Drugs and Biologicals, Coverage of, for Label and Off-Label Uses
J6 · Effective Oct 1, 2015
7 active Medicare policies list H35.059, and 5 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J6 · Effective Jul 1, 2026
National · Effective Jun 4, 2026
J9 · Effective Oct 1, 2025
5 policies from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of H35.059 |
|---|---|---|
| Age-Related Macular Degeneration | Feb 20, 2024 | Covered |
| Genetic Testing | Feb 27, 2024 | Covered |
| Macular/Foveal Translocation | Jun 7, 2023 | Covered |
| Transpupillary Thermal Therapy | Jul 14, 2023 | Covered |
| Verteporfin (Visudyne) Photodynamic Therapy | Jun 29, 2023 | Covered |